Are we any closer to optimising amblyopia treatment?

<p dir="ltr">Results indicate that while EOT may not be beneficial for every child, there is a solid evidence base for a personalised approach to its use, especially for young children with mild-to-moderate amblyopia.</p><p dir="ltr">A more granular analysis of personal factors such as age, BCVA, refraction, type of amblyopia, stereovision, and socioeconomic background, could be helpful in identifying the best treatment modality, including patching dosage, ideal frequency of clinical visits, and the most appropriate motivational/educational interventions tailored to each child.</p>